Shanghai Aohua Photoelectricity Endoscope Co Ltd
SSE:688212
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
32
65.08
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Shanghai Aohua Photoelectricity Endoscope Co Ltd
Other Long-Term Assets
Shanghai Aohua Photoelectricity Endoscope Co Ltd
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shanghai Aohua Photoelectricity Endoscope Co Ltd
SSE:688212
|
Other Long-Term Assets
¥46.7m
|
CAGR 3-Years
68%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Other Long-Term Assets
¥61.5m
|
CAGR 3-Years
67%
|
CAGR 5-Years
116%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Other Long-Term Assets
¥263.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
31%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Other Long-Term Assets
¥2.1B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Other Long-Term Assets
¥122.6m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Other Long-Term Assets
¥541.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shanghai Aohua Photoelectricity Endoscope Co Ltd
Glance View
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research, development, production, and sale of endoscope products. The company is headquartered in Shanghai, Shanghai and currently employs 865 full-time employees. The company went IPO on 2021-11-15. The firm's main businesses are the research, development, production and sales of electronic endoscopic equipment and endoscopic diagnostic and surgical consumables. The firm's products include endoscopic equipment and endoscopic diagnostic and surgical consumables. The firm's products are mainly used in clinical departments such as gastroenterology, respiratory, ears, nose, and throat (ENT), gynecology, and emergency departments.
See Also
What is Shanghai Aohua Photoelectricity Endoscope Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
46.7m
CNY
Based on the financial report for Dec 31, 2023, Shanghai Aohua Photoelectricity Endoscope Co Ltd's Other Long-Term Assets amounts to 46.7m CNY.
What is Shanghai Aohua Photoelectricity Endoscope Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
35%
Over the last year, the Other Long-Term Assets growth was 47%. The average annual Other Long-Term Assets growth rates for Shanghai Aohua Photoelectricity Endoscope Co Ltd have been 68% over the past three years , 35% over the past five years .
You don't have any saved screeners yet
